Predicting patient-specific response to adaptive therapy in metastatic castration-resistant prostate cancer using prostate-specific antigen dynamics

Abiraterone acetate (AA) has been proven effective for metastatic castration-resistant prostate cancer (mCRPC), and it has been proposed that adaptive AA may reduce toxicity and prolong time to progression, when compared to continuous AA. We developed a simple quantitative model of prostate-specific...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Renee Brady-Nicholls, Jingsong Zhang, Tian Zhang, Andrew Z. Wang, Robert Butler, Robert A. Gatenby, Heiko Enderling
Formato:	Artigo
Idioma:	Inglês
Publicado em:	Elsevier 2021-09-01
Colecção:	Neoplasia: An International Journal for Oncology Research
Assuntos:	Prostate cancer Metastatic Mathematical Modeling Predictive Adaptive therapy
Acesso em linha:	http://www.sciencedirect.com/science/article/pii/S1476558621000543
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!